MCP Danish Cancer Society
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.M400118-MCP200 on January 17, 2005.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M400118-MCP200v1
4/4/356    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thelemann, A.
Right arrow Articles by Haley, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thelemann, A.
Right arrow Articles by Haley, J. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 4:356-376, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

Research

Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells*,S

April Thelemann{ddagger}, Filippo Petti{ddagger}, Graeme Griffin{ddagger}, Ken Iwata§, Tony Hunt, Tina Settinari||, David Fenyo**,{ddagger}{ddagger}, Neil Gibson{ddagger} and John D. Haley{ddagger},§§

From {ddagger} OSI Pharmaceuticals, Inc., Farmingdale, NY 11735 and § Wilderness Drive, Boulder, CO 80301; Applied Biosystems, Inc., Framingham, MA 01701 and || Foster City, CA 94404; and ** Proteometrics, New York, NY 10018

Overexpression and enhanced activation of the epidermal growth factor (EGF) receptor are frequent events in human cancers that correlate with poor prognosis. Anti-phosphotyrosine and anti-EGFr affinity chromatography, isotope-coded µLC-MS/MS, and immunoblot methods were combined to describe and measure signaling networks associated with EGF receptor activation and pharmacological inhibition. The squamous carcinoma cell line HN5, which overexpresses EGF receptor and displays sustained receptor kinase activation, was used as a model system, where pharmacological inhibition of EGF receptor kinase by erlotinib markedly reduced auto and substrate phosphorylation, Src family phosphorylation at EGFR Y845, while increasing total EGF receptor protein. Diverse sets of known and poorly described functional protein classes were unequivocally identified by affinity selection, comprising either proteins tyrosine phosphorylated or complexed therewith, predominantly through EGF receptor and Src family kinases, principally 1) immediate EGF receptor signaling complexes (18%); 2) complexes involved in adhesion and cell-cell contacts (34%); and 3) receptor internalization and degradation signals. Novel and known phosphorylation sites could be located despite the complexity of the peptide mixtures. In addition to interactions with multiple signaling adaptors Grb2, SHC, SCK, and NSP2, EGF receptors in HN5 cells were shown to form direct or indirect physical interactions with additional kinases including ACK1, focal adhesion kinase (FAK), Pyk2, Yes, EphA2, and EphB4. Pharmacological inhibition of EGF receptor kinase activity by erlotinib resulted in reduced phosphorylation of downstream signaling, for example through Cbl/Cbl-B, phospholipase C{gamma} (PLC{gamma}), Erk1/2, PI-3 kinase, and STAT3/5. Focal adhesion proteins, FAK, Pyk2, paxillin, ARF/GIT1, and plakophillin were down-regulated by transient EGF stimulation suggesting a complex balance between growth factor induced kinase and phosphatase activities in the control of cell adhesion complexes. The functional interactions between IGF-1 receptor, lysophosphatidic acid (LPA) signaling, and EGF receptor were observed, both direct and/or indirectly on phospho-Akt, phospho-Erk1/2, and phospho-ribosomal S6.

§§ To whom correspondence should be addressed: OSI Pharmaceuticals, Inc., 1 Bioscience Park Drive, Farmingdale, NY 11735. Tel.: 631-962-0709; Fax: 631-845-5671; E-mail: jhaley{at}osip.com


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
U. Kruse, M. Bantscheff, G. Drewes, and C. Hopf
Chemical and Pathway Proteomics: Powerful Tools for Oncology Drug Discovery and Personalized Health Care
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1887 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. L. Mueller, L. A. Hunter, S. P. Ethier, and J. L. Boerner
Met and c-Src Cooperate to Compensate for Loss of Epidermal Growth Factor Receptor Kinase Activity in Breast Cancer Cells
Cancer Res., May 1, 2008; 68(9): 3314 - 3322.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Guo, J. Villen, J. Kornhauser, K. A. Lee, M. P. Stokes, K. Rikova, A. Possemato, J. Nardone, G. Innocenti, R. Wetzel, et al.
Signaling networks assembled by oncogenic EGFR and c-Met
PNAS, January 15, 2008; 105(2): 692 - 697.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
Y. Wang and R. L. Klemke
PhosphoBlast, a Computational Tool for Comparing Phosphoprotein Signatures among Large Datasets
Mol. Cell. Proteomics, January 1, 2008; 7(1): 145 - 162.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
S. Lemeer, R. Ruijtenbeek, M. W. H. Pinkse, C. Jopling, A. J. R. Heck, J. den Hertog, and M. Slijper
Endogenous Phosphotyrosine Signaling in Zebrafish Embryos
Mol. Cell. Proteomics, December 1, 2007; 6(12): 2088 - 2099.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
Y. Chen, L.-Y. Choong, Q. Lin, R. Philp, C.-H. Wong, B.-K. Ang, Y.-L. Tan, M.-C.-S. Loh, C.-L. Hew, N. Shah, et al.
Differential Expression of Novel Tyrosine Kinase Substrates during Breast Cancer Development
Mol. Cell. Proteomics, December 1, 2007; 6(12): 2072 - 2087.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. J. Barnes, K. Ohshiro, S. K. Rayala, A. K. El-Naggar, and R. Kumar
Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer
Clin. Cancer Res., July 15, 2007; 13(14): 4291 - 4299.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Fitsialos, A.-A. Chassot, L. Turchi, M. A. Dayem, K. LeBrigand, C. Moreilhon, G. Meneguzzi, R. Busca, B. Mari, P. Barbry, et al.
Transcriptional Signature of Epidermal Keratinocytes Subjected to in Vitro Scratch Wounding Reveals Selective Roles for ERK1/2, p38, and Phosphatidylinositol 3-Kinase Signaling Pathways
J. Biol. Chem., May 18, 2007; 282(20): 15090 - 15102.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Konishi, K. Tashiro, Y. Murata, H. Nabeshi, E. Yamauchi, and H. Taniguchi
CFBP Is a Novel Tyrosine-phosphorylated Protein That Might Function as a Regulator of CIN85/CD2AP
J. Biol. Chem., September 29, 2006; 281(39): 28919 - 28931.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Tashiro, H. Konishi, E. Sano, H. Nabeshi, E. Yamauchi, and H. Taniguchi
Suppression of the Ligand-mediated Down-regulation of Epidermal Growth Factor Receptor by Ymer, a Novel Tyrosine-phosphorylated and Ubiquitinated Protein
J. Biol. Chem., August 25, 2006; 281(34): 24612 - 24622.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
J. C. Trinidad, C. G. Specht, A. Thalhammer, R. Schoepfer, and A. L. Burlingame
Comprehensive Identification of Phosphorylation Sites in Postsynaptic Density Preparations
Mol. Cell. Proteomics, May 1, 2006; 5(5): 914 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Thomson, E. Buck, F. Petti, G. Griffin, E. Brown, N. Ramnarine, K. K. Iwata, N. Gibson, and J. D. Haley
Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non-Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition
Cancer Res., October 15, 2005; 65(20): 9455 - 9462.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
Y. Zhang, A. Wolf-Yadlin, P. L. Ross, D. J. Pappin, J. Rush, D. A. Lauffenburger, and F. M. White
Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules
Mol. Cell. Proteomics, September 1, 2005; 4(9): 1240 - 1250.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
E. Boeri Erba, E. Bergatto, S. Cabodi, L. Silengo, G. Tarone, P. Defilippi, and O. N. Jensen
Systematic Analysis of the Epidermal Growth Factor Receptor by Mass Spectrometry Reveals Stimulation-dependent Multisite Phosphorylation
Mol. Cell. Proteomics, August 1, 2005; 4(8): 1107 - 1121.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
F. Petti, A. Thelemann, J. Kahler, S. McCormack, L. Castaldo, T. Hunt, L. Nuwaysir, L. Zeiske, H. Haack, L. Sullivan, et al.
Temporal quantitation of mutant Kit tyrosine kinase signaling attenuated by a novel thiophene kinase inhibitor OSI-930
Mol. Cancer Ther., August 1, 2005; 4(8): 1186 - 1197.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.